FreeTender

This is a dynamic purchasing system or similar standing arrangement, not a one-off tender.

Suppliers can apply to join at any time until 5 October 2028. The buyer then invites admitted suppliers to compete for individual contracts, each with its own short deadline.

Open to joinDynamic purchasing systemGermany

Germany – Pharmaceutical products – Open-House-Verträge 2026 - Aflibercept (Kopie)

Germany – Pharmaceutical products – Open House Contracts 2026 - Aflibercept (copy)English, machine translated

Issued by AOK Bremen/Bremerhaven · via TED — Tenders Electronic Daily (EU)

Published
25 Sept 2026
Open to join until
5 Oct 2028, 23:59 UTC
Reference
663636-2026
Location
Germany
Sector
Healthcare & Pharma
Type
goods

At a glance

AOK Bremen/Bremerhaven in Germany has published an open-admission purchasing arrangement in healthcare & pharma: “Germany – Pharmaceutical products – Open-House-Verträge 2026 - Aflibercept (Kopie)”. Suppliers can apply to join until 5 October 2028. Quote reference 663636-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 5 notices from this buyer since 2026, 5 of them currently open. There are 832 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

English summary

Machine translated from German by FreeTender. The original notice below is the binding text.

Open House Contracts for active ingredients up to 30.11.2028 Lots Lot 1 — Aflibercept ATC Code S01LA05: In the Open House procedure, medicinal products are excluded according to the BfArM list according to § 35 para 5a SGB V (children’s medicinal products). The subject of this publication is the conclusion of contracts according to § 130a para 8 SGB V on various active substances within the framework of a so-called open house procedure.

Details

Open-House-Verträge für Wirkstoff bis 30.11.2028

Lots Lot 1 — Aflibercept ATC Code S01LA05: Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen. Gegenstand dieser Veröffentlichung ist der Abschluss von Verträgen nach § 130a Abs. 8 SGB V über verschiedene Wirkstoffe im Rahmen eines sogenannten Open-House-Verfahrens. Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss bzw. Beitritt zu einem Rabattvertrag nach § 130a Abs. 8 SGB V über den genannten Wirkstoff angeboten. Der früheste Vertragsbeginn ist der 01.11.2026, Vertragsende ist der 30.11.2028. Ein Beitritt zu diesem Open-House-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Bitte seien Sie so nett und übersenden uns bei Interesse, gerne vorab per E-Mail, den in 2-facher Ausfertigung unterschriebenen Rabattvertrag unter Berücksichtigung der Kinderarzneimittel-Liste des BfArM.

Buyer: AOK Bremen/Bremerhaven

Buyer country: DEU

Procedure: open

CPV code: 33600000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 5 notices from AOK Bremen/Bremerhaven, going back to September 2026 — 5 of them still open. There are 832 open Healthcare & Pharma tenders in Germany. This one closes in 692 days.

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

Who won similar contracts

Recent contract awards in Germany, from published award notices.

More contract awards →

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →